Hypermagnesemia Causes and Prevention

Primary Mechanisms Leading to Hypermagnesemia

The American Heart Association notes that hypermagnesemia most commonly results from excessive magnesium intake, particularly magnesium-containing laxatives or antacids, in the setting of impaired renal excretion, though it can occur even with normal kidney function when large amounts are ingested or retained in the gastrointestinal tract 1
The European Society of Medical Oncology recommends avoiding magnesium oxide preparations and magnesium sulfate salts due to the risk of hypermagnesemia 2, 3
The American College of Cardiology states that iatrogenic magnesium administration, including magnesium sulfate for preterm labor in pregnant women, can contribute to hypermagnesemia 1, 4

The American Heart Association indicates that renal dysfunction is the most important predisposing factor for hypermagnesemia, and creatinine clearance <20 mL/min represents an absolute contraindication to magnesium supplementation 1, 5, 6

The American College of Cardiology notes that moderate hypermagnesemia (2.5-5 mmol/L or approximately 6-12 mg/dL) presents with prolonged PR, QRS, and QT intervals on ECG, muscular weakness, drowsiness and confusion, and vasodilation and hypotension 1, 4, 5
The American Heart Association states that severe hypermagnesemia (6-10 mmol/L or >12 mg/dL) causes atrioventricular nodal conduction block, bradycardia, complete paralysis, respiratory depression, and cardiac arrest 1, 4, 5

The European Society of Medical Oncology recommends ensuring adequate renal function before initiating magnesium supplementation, avoiding prolonged use of magnesium-containing laxatives, and regular monitoring of serum magnesium levels, especially in high-risk populations 2, 3, 5
The American College of Cardiology notes that absolute contraindications to magnesium-containing preparations include acute or chronic kidney disease with creatinine clearance <20 mL/min, bowel obstruction or severe constipation, and elderly patients with multiple comorbidities requiring close monitoring 5, 6